Assessment of Intra-Operative Atrial Fibrillation Inducibility As a Screening Tool to Prevent Post-Operative Atrial Fibrillation With Prophylaxis Amiodarone

Who is this study for? Adult patients with atrial fibrillation
What treatments are being studied? Amiodarone+Intraoperative Rapid Atrial Pacing
Status: Recruiting
Location: See location...
Intervention Type: Drug, Device
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

Patients undergoing first time cardiac surgery will undergo rapid atrial pacing prior to initiation of cardiopulmonary bypass to screen for AF inducibility. Patients with inducible AF will be randomized to prophylactic amiodarone treatment versus no treatment. Patients who are not inducible to AF will be treated with standard post-operative care. Patients will be monitored post-operatively to explore the value of intraoperative inducibility of AF to predict POAF and to evaluate whether the combination of intraoperative inducibility and precision amiodarone therapy is effective at reducing the incidence of POAF

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Patients scheduled for first-time non-emergent open-heart surgery for coronary artery bypass graft (CABG) revascularization, valvular repair or replacement, combined CABG with valve repair or replacement, or valve sparing aortic root repair

• Normal sinus rhythm

• No documented history of atrial fibrillation

Locations
United States
California
Stanford University
RECRUITING
Stanford
Contact Information
Primary
Anson Lee, MD
ansonlee@stanford.edu
650-724-7500
Time Frame
Start Date: 2017-03-01
Estimated Completion Date: 2050-12-31
Participants
Target number of participants: 600
Treatments
Active_comparator: Inducible Atrial Fibrillation
Treatment with Amiodarone
Other: Inducible Atrial Fibrillation - Standard Care
No initial Amiodarone Treatment unless POAF seen on post operative care unit.
Other: Non-Inducible Atrial Fibrillation
Amiodarone treatment if POAF seen on post-operative care unit
Related Therapeutic Areas
Sponsors
Leads: Stanford University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials